Scientist Greshun De Bouse on Pfizer Coronavirus Vaccine: Don’t Be Too Hasty

  • Pfizer's vaccine is experimental, and "If the vaccine failed to work it would be financially "painful" for the company," according to CEO Albert Bourla.
  • "Neither Pfizer, nor either of the two other companies-Moderna and AstraZeneca-who are in late-stage COVID vaccine testing should act in haste concerning producing a COVID vaccine prematurely merely for the sake of saying a vaccine is available," says Scientist De Bouse.
  • We all want a speedy resolve to this pandemic nightmare in the form of a vaccine or just a complete cure or something.

We all have had our lives interrupted in one form or another by #ronavirus or COVID-19 in this peculiar year 2020.  Considering this, we all want a speedy resolve to this pandemic nightmare in the form of a vaccine or just a complete cure or something.  But one scientists says fellow scientists and researchers should not act in haste to roll out a COVID vaccine that has not been properly tested. 

Our friend and expert scientist Greshun De Bouse says there still is much unknown about #ronavirus, and a race to just produce any vaccine could be detrimental for its recipients. According to a CNBC article published today, Pfizer’s vaccine is experimental, and “If the vaccine failed to work it would be financially “painful” for the company,” according to CEO Albert Bourla. Expert Greshun De Bouse says in response to Pfizer’s aim for a globally distributed corinavirus vaccine by the end of the year:

Greshun De Bouse.

Neither Pfizer, nor either of the two other companies-Moderna and AstraZeneca-who are in late-stage COVID vaccine testing should act in haste concerning producing a COVID vaccine prematurely merely for the sake of saying a vaccine is available.  The goal is a widespread efficacious vaccine for all, if a vaccine is to be produced and administered.

The trials under conduction have not included enough participants of varying demographics and conditions to accurately measure COVID vaccine mass efficacy.  Relatively, Pfizer has “submitted a proposal to the FDA to expand the late-stage trial to include up to 44,000 participants, a significant increase from its previous target of 30,000, according to the CNBC article released today.

In addition, by their own admission, “Pfizer’s experimental vaccine contains genetic material called messenger RNA, or mRNA, which scientists hope provokes the immune system to fight the virus.”  This is like casting your net and “hoping” to catch fish-you may or may not.

This virus is far too aggressive for the masses to be presented with an “experimental” vaccine that scientists “hope” produces the desired effect. It is absurd to even suggest such. A cure us needed, and as stated in a previous interview, my research findings for COVID cure are in alignment with that of some other prominent scientists. 

Though further testing is needed as with any potential viral eradicant, my research findings are demonstrative of “real” COVID cure-not an experimental hope.  The lives of the public are not to be toyed with.  We want this virus gone via a real solution.

Greshun is right.  We want a cure, not to be experimental guinea pigs. Kudos to Pfizer and others for their vaccine attempts, but they should not try to roll out something not properly tested which could potentially exacerbate the situation.  We all want COVID gone. It does not have to be a big company. If scientist Greshun De Bouse has the COVID cure, I’ll trust her. Like all of us, we just want the ultimate goal met. We will definitely have more on this story.

Only $1/click

Submit Your Ad Here

MTFMove Day® PR

As seen in Chase's Calendar, National Making The First Move Day® is a national advocacy holiday celebrated annually on April 7 when kids, families, and persons of all ages, demographics, and backgrounds reclaim their personal power and START MAKING THE FIRST MOVE TOWARDS BULLYING PREVENTION AND RECOVERY IN ALL FORMS
http://www.mtfmoveday.org

Leave a Reply